BioSpace News Archive

Press Releases

NeuLogiq® Platform Helps Confirm No Evidence of Psychotomimetic, Hallucinatory, or Dissociative Effects in a Phase 1b Study of a Novel Neuroplastogen Developed for Major Depressive Disorder

May 28, 2026
·
7 min read
Press Releases

DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States

May 28, 2026
·
3 min read
Press Releases

Newron Pharmaceuticals to Participate in June 2026 Investor Conferences

May 28, 2026
·
2 min read
Press Releases

Valneva to Participate at U.S. and European Investor Conferences in June 2026

May 28, 2026
·
4 min read
Press Releases

ProMIS Neurosciences to Participate in Upcoming Conferences in June 2026

May 28, 2026
·
3 min read
Press Releases

New research reveals COVID-19’s long-term impact on kids

May 28, 2026
·
3 min read
Press Releases

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

May 28, 2026
·
6 min read
Press Releases

JCR Pharmaceuticals to Present at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026 - May 28, 2026

May 28, 2026
·
8 min read
Press Releases

Draig Therapeutics Presents New Phase 1 Data Demonstrating Safety, Tolerability, Pulsatile PK and Target Engagement by DT-101, a Novel AMPA Receptor Potentiator, at ASCP Annual Meeting

May 28, 2026
·
6 min read
Press Releases

ReST Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for RST-101 for the Early Treatment of Post-Traumatic Stress Disorder (PTSD)

May 28, 2026
·
4 min read